Trident Lifeline Limited (BOM:543616)
268.00
0.00 (0.00%)
At close: Mar 2, 2026
Trident Lifeline Market Cap
Trident Lifeline has a market cap or net worth of 3.2 billion as of March 5, 2026. Its market cap has decreased by -4.43% in one year.
Market Cap
3.20B
Enterprise Value
3.82B
Revenue
1.27B
Ranking
n/a
PE Ratio
19.45
Stock Price
268.00
Market Cap Chart
Since October 10, 2022, Trident Lifeline's market cap has increased from 1.24B to 3.20B, an increase of 157.15%. That is a compound annual growth rate of 32.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 3.20B | -13.74% |
| Dec 31, 2025 | 3.71B | 15.15% |
| Dec 30, 2024 | 3.22B | 48.94% |
| Dec 29, 2023 | 2.16B | 51.61% |
| Dec 30, 2022 | 1.43B | 14.66% |
| Oct 10, 2022 | 1.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jenburkt Pharmaceuticals | 4.41B |
| Albert David | 3.88B |
| Medicamen Biotech | 3.75B |
| Medico Remedies | 3.44B |
| Amanta Healthcare | 3.42B |
| ZIM Laboratories | 3.30B |
| Everest Organics | 2.77B |
| Gennex Laboratories | 2.73B |